Key result
Endogenous IL-10 protects against myocardial ischemia-reperfusion injury by suppressing inflammation and neutrophil recruitment.
Why the study?
Does endogenous IL-10 protect the ischemic and reperfused myocardium?
Does endogenous IL-10 protect the ischemic and reperfused myocardium?
Endogenous IL-10 plays a crucial protective role in myocardial ischemia/reperfusion injury by suppressing inflammatory mediators and neutrophil recruitment.
Answers are grounded in this paper and cite their sources.
May inform anti-inflammatory strategies in myocardial I/R injury; leaves open whether IL-10 modulation translates to human cardioprotection.
The present findings provide the first direct evidence that endogenous IL-10 inhibits the production of tumor necrosis factor-alpha and NO and serves to protect the ischemic and reperfused myocardium through the suppression of neutrophil recruitment.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2000) studied this question. Endogenous interleukin-10 production protects the ischemic and reperfused myocardium by inhibiting tumor necrosis factor-alpha and nitric oxide production and suppressing neutrophil recruitment.
Synapse has enriched 10 related papers. Consider them for comparative context: